Rennova Health Inc (RNVA)
0.0001
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Rennova Health Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 22, 2024 | 17.27M |
April 19, 2024 | 17.27M |
April 18, 2024 | 17.27M |
April 17, 2024 | 17.27M |
April 16, 2024 | 15.81M |
April 15, 2024 | 14.36M |
April 12, 2024 | 17.27M |
April 11, 2024 | 15.81M |
April 10, 2024 | 17.27M |
April 09, 2024 | 17.27M |
April 08, 2024 | 17.27M |
April 05, 2024 | 17.27M |
April 04, 2024 | 17.27M |
April 03, 2024 | 14.36M |
April 02, 2024 | 14.36M |
April 01, 2024 | 14.36M |
March 28, 2024 | 14.36M |
March 27, 2024 | 14.36M |
March 26, 2024 | 17.27M |
March 25, 2024 | 14.36M |
March 22, 2024 | 14.36M |
March 21, 2024 | 14.36M |
March 20, 2024 | 14.36M |
March 19, 2024 | 14.36M |
March 18, 2024 | 17.27M |
Date | Value |
---|---|
March 15, 2024 | 15.81M |
March 14, 2024 | 14.36M |
March 13, 2024 | 14.36M |
March 12, 2024 | 15.81M |
March 11, 2024 | 14.36M |
March 08, 2024 | 15.81M |
March 07, 2024 | 17.27M |
March 06, 2024 | 17.27M |
March 05, 2024 | 17.27M |
March 04, 2024 | 17.27M |
March 01, 2024 | 14.36M |
February 29, 2024 | 17.27M |
February 28, 2024 | 14.36M |
February 27, 2024 | 14.36M |
February 26, 2024 | 17.27M |
February 23, 2024 | 14.36M |
February 22, 2024 | 14.36M |
February 21, 2024 | 17.27M |
February 20, 2024 | 17.27M |
February 16, 2024 | 17.27M |
February 15, 2024 | 14.36M |
February 14, 2024 | 14.36M |
February 13, 2024 | 14.36M |
February 12, 2024 | 14.36M |
February 09, 2024 | 17.27M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
14.14M
Minimum
Jul 05 2022
52.73M
Maximum
Mar 31 2020
25.07M
Average
20.77M
Median
Dec 31 2020
Enterprise Value Benchmarks
CEL-SCI Corp | 78.27M |
AIM ImmunoTech Inc | 8.578M |
IGC Pharma Inc | 27.13M |
NovaBay Pharmaceuticals Inc | 2.139M |
Protalix BioTherapeutics Inc | 61.89M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -1.342M |
Revenue (Quarterly) | 2.826M |
Total Expenses (Quarterly) | 3.751M |
EPS Diluted (Quarterly) | -0.0001 |